Sclerostin is positively associated with bone mineral density in men and women and negatively associated with carotid calcified atherosclerotic plaque in men from the African American-diabetes heart study

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 1, 2014, Pages 315-321

  Register, Thomas C ^a   Hruska, Keith A ^b   Divers, Jasmin ^a   Bowden, Donald W ^a   Palmer, Nicholette D ^a   Carr, J Jeffrey ^a   Wagenknecht, Lynne E ^a   Hightower, R Caresse ^a   Xu, Jianzhao ^a   Smith, S Carrie ^a   Dietzen, Dennis J ^b   Langefeld, Carl D ^a   Freedman, Barry I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN; SCLEROSTIN;

ADULT; AFRICAN AMERICAN; AGE; ARTICLE; BLOOD PRESSURE; BODY MASS; BONE DENSITY; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE DURATION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; ILIAC ARTERY; LIPOPROTEIN BLOOD LEVEL; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SMOKING; THORACIC SPINAL CORD; TRABECULAR BONE;

ADULT; AFRICAN AMERICANS; AGED; BIOLOGICAL MARKERS; BONE DENSITY; BONE MORPHOGENETIC PROTEINS; CAROTID ARTERY DISEASES; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; FEMALE; GENETIC MARKERS; HUMANS; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; SEX FACTORS; VASCULAR CALCIFICATION;

EID: 84892146626     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3168     Document Type: Article

References (42)

1. Carr JJ, Register TC, Hsu FC, et al. Calcified atherosclerotic plaque and bone mineral density in type 2 diabetes: the diabetes heart study. Bone. 2008;42:43-52.
2. Divers J, Register TC, Langefeld CD, et al. Relationships between calcified atherosclerotic plaque and bone mineral density in African Americans with type 2 diabetes. J Bone Miner Res. 2011;26:1554-1560.
3. Anderson J, Barnett E, Nordin BE. The relation between osteoporosis and aortic calcification. Br J Radiol. 1964;37:910-912.
4. Elkeles A. A comparative radiological study of calcified atheroma in males and females over 50 years of age. Lancet. 1957;273:714-715.
5. Browner WS, Pressman AR, Nevitt MC, Cauley JA, Cummings SR. Association between low bone density and stroke in elderly women. The study of osteoporotic fractures. Stroke. 1993;24:940-946.
6. Kiel DP, Kauppila LI, Cupples LA, Hannan MT, O'Donnell CJ, Wilson PW. Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study. Calcif Tissue Int. 2001;68:271-276.
7. Marcovitz PA, Tran HH, Franklin BA, O'Neill WW, Yerkey M, Boura J, Kleerekoper M, Dickinson CZ. Usefulness of bone mineral density to predict significant coronary artery disease. Am J Cardiol. 2005;96:1059-1063.
8. Ness J, Aronow WS. Comparison of prevalence of atherosclerotic vascular disease in postmenopausal women with osteoporosis or osteopenia versus without osteoporosis or osteopenia. Am J Cardiol. 2006;97:1427-1428.
9. Silverman SL, Delmas PD, Kulkarni PM, Stock JL, Wong M, Plouffe L Jr. Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women with osteoporosis. J Am Geriatr Soc. 2004;52:1543-1548.
10. Tankó LB, Christiansen C, Cox DA, Geiger MJ, McNabb MA, Cummings SR. Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res. 2005; 20:1912-1920.
11. Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V. Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab. 2004;89:4246-4253.
12. Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 1998;12:1260-1268.
13. El-Maadawy S, Kaartinen MT, Schinke T, Murshed M, Karsenty G, McKee MD. Cartilage formation and calcification in arteries of mice lacking matrix Gla protein. Connect Tissue Res. 2003;44 Suppl 1:272-278.
14. Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997; 390:45-51.
15. Newman AB, Naydeck BL, Whittle J, Sutton-Tyrrell K, Edmundowicz D, Kuller LH. Racial differences in coronary artery calcification in older adults. Arterioscler Thromb Vasc Biol. 2002;22:424-430.
16. Freedman BI, Hsu FC, Langefeld CD, et al. The impact of ethnicity and sex on subclinical cardiovascular disease: the Diabetes Heart Study. Diabetologia. 2005;48:2511-2518.
17. Bild DE, Detrano R, Peterson D, et al. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2005;111:1313-1320.
18. Carnethon MR, Bertoni AG, Shea S, et al. Racial/ethnic differences in subclinical atherosclerosis among adults with diabetes: the Multiethnic Study of Atherosclerosis. Diabetes Care. 2005;28:2768-2770.
19. Budoff MJ, Nasir K, Mao S, et al. Ethnic differences of the presence and severity of coronary atherosclerosis. Atherosclerosis. 2006;187:343-350.
20. Young BA, Maynard C, Boyko EJ. Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. Diabetes Care. 2003;26:2392-2399.
21. Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV. Ethnic disparities in diabetic complications in an insured population. JAMA. 2002;287:2519-2527.
22. Young BA, Rudser K, Kestenbaum B, Seliger SL, Andress D, Boyko EJ. Racial and ethnic differences in incident myocardial infarction in end-stage renal disease patients: the USRDS. Kidney Int. 2006;69:1691-1698.
23. Aloia JF. African Americans, 25-hydroxyvitamin D, and osteoporosis: a paradox. Am J Clin Nutr 2008;88:545S-550S.
24. Freedman BI, Wagenknecht LE, Hairston KG, et al. Vitamin d, adiposity, and calcified atherosclerotic plaque in African-Americans. J Clin Endocrinol Metab. 2010;95:1076-1083.
25. Freedman BI, Register TC. Effect of race and genetics on vitamin D metabolism, bone and vascular health. Nat Rev Nephrol. 2012;8:459-466.
26. Ke HZ, Richards WG, Li X, Ominsky MS. Sclerostin and Dick- kopf-1 as Therapeutic Targets in Bone Diseases. Endocr Rev. 2012; 33:747-783.
27. Balemans W, Piters E, Cleiren E, et al. The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations. Calcif Tissue Int. 2008;82:445-453.
28. Estrada K, Styrkarsdottir U, Evangelou E, et al. Genome-wide metaanalysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet. 2012;44:491-501.
29. Didangelos A, Yin X, Mandal K, Baumert M, Jahangiri M, Mayr M. Proteomics characterization of extracellular space components in the human aorta. Mol Cell Proteomics. 2010;9:2048-2062.
30. Zhu D, Mackenzie NC, Millán JL, Farquharson C, MacRae VE. The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells. PLoS One. 2011;6: e19595.
31. Morales-Santana S, García-Fontana B, García-Martín A, et al. Atherosclerotic disease in type 2 diabetes is associated with an increase in sclerostin levels. Diabetes Care. 2013;36:1667-1674.
32. Hampson G, Edwards S, Conroy S, Blake GM, Fogelman I, Frost ML. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women. Bone. 2013;56:42-47.
33. Box GE, Cox DR. Ananalysis of transformations. J Roy Stat Soc Ser. 1964;26:211-246.
34. Szulc P, Bertholon C, Borel O, Marchand F, Chapurlat R. Lower fracture risk in older men with higher sclerostin concentration: A prospective analysis from the MINOS study. J Bone Miner Res. 2013;28:855-864.
35. Szulc P, Boutroy S, Vilayphiou N, et al. Correlates of bone microarchitectural parameters and serum sclerostin levels in men: the STRAMBO study. J Bone Miner Res. 2013;28:1760-1770.
36. Garnero P, Sornay-Rendu E, Munoz F, Borel O, Chapurlat RD. Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study. Osteoporos Int. 2013; 24:489-494.
37. Gaudio A, Pennisi P, Bratengeier C, et al. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab. 2010;95:2248-2253.
38. Amrein K, Amrein S, Drexler C, et al. Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults. J Clin Endocrinol Metab. 2012; 97:148-154.
39. Lapauw B, Vandewalle S, Taes Y, et al. Serum sclerostin levels in menwith idiopathic osteoporosis. Eur J Endocrinol. 2013;168:615-620.
40. Register TC, Hruska KA, Divers J, et al. Plasma Dickkopf1 (DKK1) concentrations negatively associate with atherosclerotic calcified plaque in African-Americans with type 2 diabetes. J Clin Endocrinol Metab. 2013;98:E60-E65.
41. Thambiah S, Roplekar R, Manghat P, et al. Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness. Calcif Tissue Int. 2012;90:473-480.
42. Pelletier S, Dubourg L, Carlier MC, Hadj-Aissa A, Fouque D. The relation between renal function and serum sclerostin in adult patients with CKD. Clin J Am Soc Nephrol. 2013;8:819-823.